Peerbridge Health received FDA clearance for Cor MDx.
SEP 14, 2026
Peerbridge Health announced a $7M funding round.
SEP 17, 2025
Peerbridge Health provides a clinician-first cardiac intelligence platform combining an FDA-cleared wearable ambulatory ECG monitor with clinical software to deliver high-fidelity cardiac signals and decision-ready insights
Peerbridge Health provides a clinician-first cardiac intelligence platform combining an FDA-cleared wearable ambulatory ECG monitor with clinical software to deliver high-fidelity cardiac signals and decision-ready insights. Its Cor MDx platform supports remote cardiac monitoring, earlier detection and triage, and physician-led care across clinics, hospitals, and the home. AI-supported analysis helps clinicians review cardiac data while preserving physician interpretation and control.